|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Patento numeris | 3458084 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17725143.6 |
| Europos patento paraiškos padavimo data | 2017-05-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/032714 |
| Data | 2017-05-15 |
| (87) | Numeris | WO 2017/200943 |
| Data | 2017-11-23 |
| (30) | Numeris | Data | Šalis |
| 201662337005 P | 2016-05-16 | US | |
| 201662414146 P | 2016-10-28 | US | |
| 201662420937 P | 2016-11-11 | US |
| (72) |
BLACKWELL, William, US
SRIVASTAVA, Ved P., US
PAULIK, Mark A., US
YOUNG, Andrew, US
DOCK, Steven Thomas, US
HUNTER, III Robert Neil, US
|
| (73) |
Intarcia Therapeutics, Inc,
One Marina Park Drive 13th Floor, Boston, MA 02210,
US
|
| (54) | GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |
| GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |